Max Chat
Company Analysis Ajanta Pharma Limited
1. Summary
Advantages
- Current debt level 0.7606% is below 100% and has decreased over 5 years from 1.33%.
- The company's current efficiency (ROE=23.47%) is higher than the sector average (ROE=10.54%)
Disadvantages
- Price (2634.2 βΉ) is higher than fair price (745.38 βΉ)
- Dividends (0.8425%) are below the sector average (9.06%).
- The stock's return over the last year (-11.3%) is lower than the sector average (22.71%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Ajanta Pharma Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1.5% | 4.5% | -1.4% |
| 90 days | 6.6% | 10.9% | 9.4% |
| 1 year | -11.3% | 22.7% | 2% |
AJANTPHARM vs Sector: Ajanta Pharma Limited has significantly underperformed the "Healthcare" sector by -34.02% over the past year.
AJANTPHARM vs Market: Ajanta Pharma Limited has significantly underperformed the market by -13.27% over the past year.
Stable price: AJANTPHARM is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.
Long period: AJANTPHARM with weekly volatility of -0.2174% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (2634.2 βΉ) is higher than the fair price (745.38 βΉ).
Price is higher than fair: The current price (2634.2 βΉ) is 71.7% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (33.23) is lower than that of the sector as a whole (59.52).
P/E vs Market: The company's P/E (33.23) is lower than that of the market as a whole (66.04).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (7.6) is higher than that of the sector as a whole (6.59).
P/BV vs Market: The company's P/BV (7.6) is higher than that of the market as a whole (6.6).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (6.44) is lower than that of the sector as a whole (9.3).
P/S vs Market: The company's P/S indicator (6.44) is lower than that of the market as a whole (18.95).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (21.51) is lower than that of the sector as a whole (141.59).
EV/Ebitda vs Market: The company's EV/Ebitda (21.51) is lower than that of the market as a whole (24.96).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 14.9% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (14.9%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-3.49%).
5.4. ROE
ROE vs Sector: The company's ROE (23.47%) is higher than that of the sector as a whole (10.54%).
ROE vs Market: The company's ROE (23.47%) is higher than that of the market as a whole (3.54%).
5.5. ROA
ROA vs Sector: The company's ROA (17.52%) is higher than that of the sector as a whole (7.51%).
ROA vs Market: The company's ROA (17.52%) is higher than that of the market as a whole (7.89%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (32.35%) is higher than that of the sector as a whole (16.06%).
ROIC vs Market: The company's ROIC (32.35%) is higher than that of the market as a whole (15.45%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.8425% is below the average for the sector '9.06%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.8425% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 0.8425% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (78.68%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
